DISCLAIMER: PRINTED COPIES ARE FOR REFERENCE ONLY. PLEASE REFER TO THE ELECTRONIC COPY FOR THE LATEST VERSION.
PEDIATRIC TREATMENT PROTOCOL S-165
POISONING / OVERDOSE
Date: 7/1/2025 Page 1 of 1
BLS ALS
• Ensure patent airway
• O2 saturation PRN
• O2 and/or ventilate PRN
• Monitor blood glucose PRN
• Carboxyhemoglobin monitor PRN, if available
Ingestions
• Identify substance
• Transport pill bottles and containers with patient
PRN
Skin contamination*
• Remove clothes
• Brush off dry chemicals
• Flush with copious water
Toxic inhalation (e.g., CO exposure, smoke, gas)
• Move patient to safe environment
• 100% O2 via mask
• Consider transport to facility with hyperbaric
chamber for suspected CO poisoning, particularly
in unconscious or pregnant patients
Symptomatic suspected opioid OD with RR low
for age. Use with caution in opioid-dependent,
pain-management patients
Patients <35 kg (77 lbs)
• Ventilate PRN
• Call for ALS
Patients ≥35 kg
• Naloxone 4 mg via nasal spray preloaded singledose device. Administer full dose in one nostril
OR
• Naloxone 2 mg via atomizer and syringe.
Administer 1 mg into each nostril.
EMTs may assist family or friend to medicate with
patient's prescribed naloxone in symptomatic
suspected opioid OD
• Monitor/ECG
• IV/IO Ⓐ
• Capnography
Ingestions
• Assure patient has gag reflex and is cooperative
• Activated charcoal per drug chart PO if ingestion within 60
minutes and recommended by Poison Control Center Ⓐ
• In oral hypoglycemic agent ingestion, any change in
mentation requires blood glucose check or recheck
Symptomatic suspected opioid OD with respiratory
depression (RR low for age, SpO2<96%, or EtCO2 ≥40
mmHg)
• Naloxone per drug chart IN/IV/IM, MR Ⓐ
• In opioid-dependent patients, dilute and titrate slowly per
drug chart
Symptomatic organophosphate poisoning
• Atropine per drug chart IV/IO
• For continued signs/symptoms of SLUDGE/BBB, double
prior atropine dose IV/IO q3-5 min
Extrapyramidal reactions
• Diphenhydramine per drug chart slow IV/IM
Suspected tricyclic antidepressant OD with cardiac
effects (e.g., hypotension, heart block, or widened QRS)
• NaHCO3 per drug chart IV/IO
Suspected beta blocker or calcium channel blocker OD,
contact Poison Control Center and Base Hospital‡
 Per Title 22, Division 9, Chapter 2.3, § 100027.03 public safety personnel may administer nasal naloxone when
authorized by the County of San Diego EMS Medical Director
*For radioactive material, treatment of traumatic injuries takes precedence over decontamination
‡ Base Hospital Physician may order recommendation from Poison Control Center

